The return of rep access: Report suggests bounce-back in rate of pharma-friendly docs

The increasing number of clinicians willing to meet virtually has driven the rate of rep-friendly physicians to a record high of 60% in the U.S., according to a recent report released by Veeva.

That figure, a cross-specialty tally, is up from an average of about 20% during the COVID-19 pandemic. The report shows the extent to which in-person visits, long a staple of the typical drugmaker’s marketing playbook, have been complemented by virtual meetings in the engagement mix.